Pfizer provides heady cocktail of debt

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Pfizer provides heady cocktail of debt

Issuers crammed into the market on Tuesday with pharmaceutical firm Pfizer bringing the second multi-tranche Reverse Yankee this week, while Iberdrola ratcheted in pricing on a green bond — investors said they were enjoying the busy spell.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login
Gift this article